tiprankstipranks
Tevogen Bio Holdings (DE:G280)
FRANKFURT:G280
Germany Market
G280
Tevogen Bio Holdings
RESEARCH TOOLSreports

Tevogen Bio Holdings (G280) Financial Statements

2 Followers

Tevogen Bio Holdings Financial Overview

Tevogen Bio Holdings's market cap is currently €38.04M. The company's EPS TTM is €-5.84; its P/E ratio is -1.71; Tevogen Bio Holdings is scheduled to report earnings on June 3, 2026, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Mar 25Mar 24Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ -403.58K$ -378.36K$ 0.00$ 0.00
Operating Income$ -26.14M$ -53.56M$ -8.84M$ -953.08K$ -4.62M
EBITDA$ -25.57M$ -13.14M$ -58.89M$ 4.41M$ -14.99M
Net Income$ -26.28M$ -10.11M$ -60.48M$ 4.41M$ -15.60M
Balance Sheet
Cash & Short-Term Investments$ 552.37K$ 1.28M$ 1.05M$ 5.48M$ 7.12M
Total Assets$ 4.38M$ 3.46M$ 5.51M$ 7.74M$ 7.66M
Total Debt$ 3.10M$ 2.89M$ 95.42M$ 40.01M$ 23.48M
Net Debt$ 2.55M$ 1.60M$ 94.37M$ 34.52M$ 16.36M
Total Liabilities$ 12.62M$ 10.14M$ 99.93M$ 41.69M$ 24.15M
Stockholders' Equity$ -8.23M$ -6.67M$ -94.43M$ -33.95M$ -16.49M
Cash Flow
Free Cash Flow$ -12.39M$ -12.00M$ -8.30M$ -9.13M$ -5.38M
Operating Cash Flow$ -12.33M$ -12.00M$ -8.17M$ -8.66M$ -5.27M
Investing Cash Flow$ -64.44K$ 0.00$ -133.00K$ -479.04K$ -109.73K
Financing Cash Flow$ 11.66M$ 12.23M$ 3.87M$ 7.50M$ 12.50M
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History

Income Statement >

Tevogen Bio Holdings Debt to Assets

Balance Sheet >

Tevogen Bio Holdings Cash Flow

Cash Flow >

Tevogen Bio Holdings Forecast EPS vs Actual EPS

Earnings >